ImmPACT Bio USA INC
4010 Adolfo Road
SuiteA
Camarillo
California
93012
United States
Tel: 8055067773
7 articles with ImmPACT Bio USA INC
-
ImmPACT Bio Names Sylvain Roy as Chief Technology Officer
5/10/2022
ImmPACT Bio USA , Inc. today announced the appointment of Sylvain Roy as chief technology officer.
-
Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.
-
ImmPACT Bio Names Venkat Yepuri as Chief Operating Officer
4/19/2022
ImmPACT Bio USA , Inc. today announced the appointment of Venkata (Venkat) P. Yepuri as chief operating officer.
-
Money on the Move: January 19 – 25
1/26/2022
Temps are falling and so is investor cash. Here's which biotech companies are scooping up the dollars this week. -
ImmPACT Bio Closes $111 Million Series B Financing, Names New Board Chair and New President and CEO, and Updates on Phase 1 Clinical Study in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
1/20/2022
ImmPACT Bio USA, Inc., a clinical-stage company developing transformative logic-gate based chimeric antigen receptor T-cell therapies for treating cancer, announced it has closed $111 million in Series B financing, led by venBio Partners along with co-leads Foresite Capital and Decheng Capital.
-
ImmPACT Bio provided an optimistic update on a Phase I clinical study evaluating its CD19-CD20 bi-specific Chimeric Antigen Receptor T-cell (CAR-T) therapy.
-
ImmPACT Bio Announces Completion of Merger with Kalthera to Progress Next-Generation CAR T Therapies for the Treatment of Cancer
7/22/2021
ImmPACT Bio USA, Inc., a company developing novel cell therapies for treating cancer, announced its merger with Kalthera, Inc., a biotechnology company.